<ARTICLE> 5 <LEGEND> THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONDENSED CONSOLIDATED BALANCE SHEETS, CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS REPORTED IN FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 26, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <MULTIPLIER> 1,000 <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> MAR-31-2000 <PERIOD-START> APR-01-1999 <PERIOD-END> SEP-26-1999 <CASH> 13,747 <SECURITIES> 35,936 <F1> <RECEIVABLES> 24,797 <ALLOWANCES> 414 <INVENTORY> 24,275 <CURRENT-ASSETS> 102,789 <PP&E> 24,024 <F2> <DEPRECIATION> 0 <TOTAL-ASSETS> 126,813 <CURRENT-LIABILITIES> 26,391 <BONDS> 4,588 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 11 <OTHER-SE> 95,823 <TOTAL-LIABILITY-AND-EQUITY> 126,813 <SALES> 74,451 <TOTAL-REVENUES> 74,451 <CGS> 58,568 <TOTAL-COSTS> 58,568 <OTHER-EXPENSES> 10,406 <F3> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 301 <INCOME-PRETAX> (1,776) <INCOME-TAX> 58 <INCOME-CONTINUING> (1,834) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (1,834) <EPS-BASIC> (0.18) <F4> <EPS-DILUTED> (0.18) <FN> <F1> Securities, Item 5-02(2), are net of accrued interest and unrealized gain/loss. <F2> Item shown net of allowance, consistent with the balance sheet presentation. <F3> Item consists of research and development. <F4> Item consists of basic earnings per share. </FN>